Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use

Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use

US Patent 11655216 · Granted May 23, 2023

Estimated economic value: $435,980,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclopentapyrrole orexin receptor agonists2025
Compounds for degrading alpha-synuclein aggregates and uses thereof2025
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors2025
Pyrrolidine orexin receptor agonists2025
Pyrrolidine orexin receptor agonists2025
Heteroaryl pyrrolidine and piperidine orexin receptor agonists2025
Small molecule inhibitors of KRAS G12C mutant2025
Thyroid hormone receptor agonists and use thereof2025
Small molecule inhibitors of KRAS G12C mutant2025
Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) in2025
Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) in2025
Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhi2025